Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human lung-resident mucosal-associated invariant T cells are abundant, express antimicrobial proteins, and are cytokine responsive. | Commun Biol | 2022 | 36085311 | PubTator, text mining | PubMed |
| Integration of Transcriptome and Epigenome to Identify and Develop Prognostic Markers for Ovarian Cancer. | J Oncol | 2022 | 36081667 | PubTator, text mining | PubMed |
| Sex Differences in Coronary Artery Disease and Diabetes Revealed by scRNA-Seq and CITE-Seq of Human CD4+ T Cells. | Int J Mol Sci | 2022 | 36077273 | PubTator, text mining | PubMed |
| Blood RNA Sequencing Indicates Upregulated BATF2 and LY6E and Downregulated ISG15 and MT2A Expression in Children with Autism Spectrum Disorder. | Int J Mol Sci | 2022 | 36077244 | PubTator, text mining | PubMed |
| In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective. | Front Cell Infect Microbiol | 2022 | 36072227 | PubTator, text mining | PubMed |
| Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling. | Immunity | 2022 | 36070768 | PubTator, text mining | PubMed |
| Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses. | Cell Rep | 2022 | 36070690 | PubTator, text mining | PubMed |
| Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression. | J Exp Med | 2022 | 36066491 | PubTator, text mining | PubMed |
| Protocol for the isolation of CD8+ tumor-infiltrating lymphocytes from human tumors and their characterization by single-cell immune profiling and multiome. | STAR Protoc | 2022 | 36065294 | PubTator, text mining | PubMed |
| Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD Patients. | Can J Gastroenterol Hepatol | 2022 | 36060521 | PubTator, text mining | PubMed |
| Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities. | Front Mol Biosci | 2022 | 36060249 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of diabetic kidney disease by microarray data analysis. | Front Pharmacol | 2022 | 36059966 | PubTator, text mining | PubMed |
| Stem-like T cells and niches: Implications in human health and disease. | Front Immunol | 2022 | 36059484 | PubTator, text mining | PubMed |
| CD8+ T cells in neurodegeneration: friend or foe? | Mol Neurodegener | 2022 | 36056406 | PubTator, text mining | PubMed |
| Heterogeneity and transcriptome changes of human CD8+ T cells across nine decades of life. | Nat Commun | 2022 | 36050300 | PubTator, text mining | PubMed |
| SARS-CoV-2 requires acidic pH to infect cells. | Proc Natl Acad Sci U S A | 2022 | 36048924 | PubTator, text mining | PubMed |
| Autopsy findings of COVID-19 in children: a systematic review and meta-analysis. | Forensic Sci Med Pathol | 2022 | 36048325 | PubTator, text mining | PubMed |
| Intestinal cellular heterogeneity and disease development revealed by single-cell technology. | Cell Regen | 2022 | 36045190 | PubTator, text mining | PubMed |
| Single-cell immune ecosystem and metabolism reprogramming imprinted by psoriasis niche. | Ann Transl Med | 2022 | 36034981 | PubTator, text mining | PubMed |
| Bioinformatics analysis to identify potential biomarkers and therapeutic targets for ST-segment-elevation myocardial infarction-related ischemic stroke. | Front Neurol | 2022 | 36034287 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=55